SP1作为结直肠癌中ADAMTS-8的负调节剂:功能和分子分析的证据
Yasemin Kalfa1, Feyza Nur Sav1, Meltem Alper2
1Balikesir University, Faculty of Science and Literature, Department of Molecular Biology and Genetics, Balıkesır, Turkey.
Biochimica et biophysica acta. Gene regulatory mechanisms
|January 8, 2026
概括
转录因子SP1抑制瘤抑制剂ADAMTS-1和ADAMTS-8,导致结肠直肠癌和骨肉瘤的癌症进展. 这个SP1-ADAMTS轴为癌症治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 沉默ADAMTS-8与侵袭性瘤和不良预后相关.
- 癌症中ADAMTS-8的转录调节还不清楚.
- SP1与结直肠癌 (CRC) 的不良结果有关.
研究的目的:
- 研究SP1在调节ADAMTS-8转录中的作用.
- 确定SP1对CRC和骨髓瘤瘤进展的影响.
- 探索SP1-ADAMTS轴作为一个潜在的治疗目标.
主要方法:
- 在CRC组织中分析SP1表达.
- 细胞增殖和迁移的测试.
- 路西法酶记者测定,ChIP-qPCR和EMSA证实SP1与ADAMTS-8促进体结合.
- qRT-PCR和西部斑点测试用于评估基因和蛋白质表达.
主要成果:
- SP1过度表达增加了CRC细胞的增殖和迁移,同时抑制了ADAMTS-1和ADAMTS-8.
- SP1直接与ADAMTS-8促进体结合,抑制其活动.
- 较低的ADAMTS-1水平与CRC患者的生存率低下有关.
- 在骨肉瘤中,SP1升高,ADAMTS-8被抑制,高的ADAMTS-8与更好的生存相关.
结论:
- SP1作为ADAMTS-1和ADAMTS-8的关键负调节剂.
- SP1-ADAMTS轴有助于CRC和骨髓瘤中的瘤进展.
- 这个监管网络为新型癌症生物标志物和治疗方法提供了潜在的目标.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...


